Mannosidase IA is in Quality Control Vesicles and Participates in Glycoprotein Targeting to ERAD

• The removal of alpha 1,2 mannose residues from its N-glycans targets a misfolded glycoprotein to ERAD.
• We found mannosidase IA implicated in this process in addition to ER mannosidase I and the EDEMs.
• Surprisingly, mannosidase IA is not located in the Golgi but resides in QCVs.
• This adds another level of apparent redundancy in this fateful step of glycoprotein quality control.

Endoplasmic reticulum-associated degradation (ERAD) of a misfolded glycoprotein in mammalian cells requires the removal of 3–4 alpha 1,2 linked mannose residues from its N-glycans. The trimming and recognition processes are ascribed to ER Mannosidase I, the ER-degradation enhancing mannosidase-like proteins (EDEMs), and the lectins OS-9 and XTP3-B, all residing in the ER, the ER-derived quality control compartment (ERQC), or quality control vesicles (QCVs). Folded glycoproteins with untrimmed glycans are transported from the ER to the Golgi complex, where they are substrates of other alpha 1,2 mannosidases, IA, IB, and IC. The apparent redundancy of these enzymes has been puzzling for many years. We have now determined that, surprisingly, mannosidase IA is not located in the Golgi but resides in QCVs. We had recently described this type of vesicles, which carry ER α1,2 mannosidase I (ERManI). We show that the overexpression of alpha class I α1,2 mannosidase IA (ManIA) significantly enhances the degradation of ERAD substrates and its knockdown stabilizes it. Our results indicate that ManIA trims mannose residues from Man9GlcNAc2 down to Man5GlcNAc2, acting in parallel with ERManI and the EDEMs, and targeting misfolded glycoproteins to ERAD.

Graphical AbstractFigure optionsDownload high-quality image (113 K)Download as PowerPoint slide